%0 Conference Paper %B The 2nd European Stroke Organisation Conference %C Barcelona, Spain %D 2016 %F AUS
NMH
FY16 %G eng %T ENCHANTED Main Results - Trial of low-dose versus standard-dose intravenous tissue plasminogen activator in 3310 patients with acute ischaemic stroke [invited speaker]